Immune-active microenvironment in SCCOHT: Rationale for therapy with immune checkpoint blockade.

被引：0
|
作者：
Van Oudenhove, Elke [1 ]
Jelinic, Petar [1 ]
Ricca, Jacob [2 ]
Narciso, Olvera [1 ]
Merghoub, Taha
Levine, Douglas A. [1 ]
Zamarin, Dmitriy [2 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
D O I：
10.1158/1557-3265.OVCA17-B26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B26
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [21] The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
    Petitprez, Florent
    Meylan, Maxime
    de Reynies, Aurelien
    Sautes-Fridman, Catherine
    Fridman, Wolf H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [22] Immune toxicity in post autologous transplant patients treated with brentuximab vedotin in combination with immune checkpoint blockade.
    Diefenbach, Catherine S. Magid
    Hong, Fangxin
    Ambinder, Richard F.
    Cohen, Jonathon Brett
    David, Kevin Andrew
    Advani, Ranjana H.
    Robertson, Michael J.
    Fenske, Timothy S.
    Barta, Stefan K.
    Palmisano, Neal
    Svoboda, Jakub
    Morgan, David S.
    Karmali, Reem
    Kahl, Brad
    Ansell, Stephen M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] The immune landscape and response to immune checkpoint blockade therapy in lymphoma
    Kline, Justin
    Godfrey, James
    Ansell, Stephen M.
    BLOOD, 2020, 135 (08) : 523 - 533
  • [24] Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade.
    Gu, Shengqing
    Zhang, Wubing
    Wang, Xiaoqing
    Jiang, Peng
    Traugh, Nicole
    Li, Ziyi
    Meyer, Clifford
    Stewig, Blair
    Xie, Yingtian
    Bu, Xia
    Manos, Michael
    Font-Tello, Alba
    Gjini, Evisa
    Lako, Ana
    Lim, Klothilda
    Conway, Jake
    Tewari, Alok
    Zeng, Zexian
    Das Sahu, Avinash
    Tokheim, Collin
    Weirather, Jason L.
    Fu, Jingxin
    Zhang, Yi
    Kroger, Benjamin
    Liang, Jin Hua
    Cejas, Paloma
    Freeman, Gordon J.
    Rodig, Scott J.
    Long, Henry
    Gewurz, Benjamin E.
    Hodi, F. Stephen
    Brown, Myles
    Liu, X. Shirley
    CANCER RESEARCH, 2021, 81 (13)
  • [25] Exercise training boosts CTL infiltration and sensitizes tumors to immune checkpoint blockade.
    Gomes-Santos, Igor L.
    CANCER RESEARCH, 2021, 81 (13)
  • [26] Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
    Zemek, Rachael M.
    Chin, Wee Loong
    Nowak, Anna K.
    Millward, Michael J.
    Lake, Richard A.
    Lesterhuis, W. Joost
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [27] The role of neoantigen in immune checkpoint blockade therapy
    Yi, Ming
    Qin, Shuang
    Zhao, Weiheng
    Yu, Shengnan
    Chu, Qian
    Wu, Kongming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2018, 7
  • [28] Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade
    Oh, Kyu-Young
    Hong, Seong-Doo
    Yoon, Hye-Jung
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2024, 53 (03) : 217 - 225
  • [29] Immune Checkpoint Blockade in Breast Cancer Therapy
    Bu, Xia
    Yao, Yihui
    Li, Xiaoyu
    TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE, 2017, 1026 : 383 - 402
  • [30] Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
    Wei, Spencer C.
    Duffy, Colm R.
    Allison, James P.
    CANCER DISCOVERY, 2018, 8 (09) : 1069 - 1086
12345